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Background: Although the use of continuous epidural infusion
(CEI) and patient-controlled epidural analgesia (PCEA) has become
commonplace in pain management, there is still controversy
regarding the relative effects of mass, volume and concentration of
the local anaesthetic. This prospective study evaluated the influence
of two concentrations of levobupivacaine on the quality of analgesia
in two modes of delivery after lower abdominal surgery.
Methods: Eighty-two patients were randomly assigned to four
groups to receive combined low thoracic epidural analgesia and
general anaesthesia followed by post-operative CEI or PCEA
using 1.5 or 5 mg/ml levobupivacaine (15 mg/h in CEI and
bolus 5 mg, lockout 20 min in PCEA). Sensory block, pain
scores, levobupivacaine and rescue morphine consumption,
motor blockade, haemodynamics, side-effects and patient satis-
faction were registered within 48 h.
Results: The four groups were similar with regard to demo-
graphics, quality of analgesia, morphine consumption and satis-
faction rate. No difference in the quality of analgesia was
observed for the two modes of delivery with regard to the
concentration of levobupivacaine, but the consumption of the
local anaesthetic was higher in the CEI groups. The Bromage
scores in the PCEA groups were reduced to zero for all except
one patient, whereas eight patients presented scores of one or
more in the CEI population.
Conclusion: Levobupivacaine in thoracic epidurals provides an
equal quality of post-operative analgesia in low and high
volume independent of the delivery mode, i.e. CEI or PCEA.
This is in accordance with the assumption that the total dose of
the local anaesthetic determines the quality of analgesia.
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BOTH continuous epidural infusion (CEI) of localanaesthetics and patient-controlled epidural
analgesia (PCEA) have been shown to be safe and
effective in the management of post-operative pain
(1—3). Although the use of such analgesic modalities
has become commonplace, there is still controversy
with regard to the relative effects of the mass,
volume and concentration of local anaesthetic solu-
tion in both delivery modes. Clinical studies have
shown conflicting results, probably because of the
limited consideration of the total dose (4—8).
Bromage (9) found that it was the total local anaes-
thetic dose, and not the total volume, that deter-
mined the spread and quality of analgesia. This
has been confirmed by others, after both lumbar
and mid-thoracic epidural administration (10, 11).
For CEI, Dernedde et al. (12, 13) have demonstrated
recently that a high concentration/low volume of
local anaesthetic provides an equal quality of post-
operative analgesia as a low-concentration/high-
volume infusion and induces less motor blockade
and haemodynamic repercussions. In PCEA, a few
studies have evaluated the influence of the volume
and concentration of local anaesthetic for abdominal
surgery, but the results are conflicting (3, 14—17).
The question arises as to whether the mode of deliv-
ery influences the quality of post-operative analge-
sia, and whether the volume and concentration of
the local anaesthetic have a further impact.
Therefore, we designed this prospective, blind,
randomised study to compare CEI vs. PCEA using
two concentrations of opioid-free levobupivacaine.
The goals of this study were to investigate the
impact of the dose, volume and concentration of
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the local anaesthetic in the two modes of delivery on
the quality of analgesia and the incidence of side-
effects after lower abdominal surgery.
Materials and methods
Following approval by the Ethics Committee, written
informed consent was obtained from 90 consecutive
ASA physical status I—III patients undergoing elec-
tive lower abdominal surgery. Patients were
included if they were 18—75 years of age, were able
to read and understand French and to use the PCEA
device, had normal mental health and had been
hospitalised for elective surgery. Exclusion criteria
were sepsis, allergy to amide-type local anaesthetics
or morphine and coagulopathy. Patients were also
excluded if they received chronic pain therapy. At
the time of the pre-operative visit, patients were
familiarised with a 10-cm visual analogue scale
(VAS) device for pain (0, no pain at all; 10, worst
imaginable pain) and nausea (0, no nausea at all; 10,
worst imaginable nausea) intensity assessment (18).
Patients were pre-medicated with midazolam
before the induction of anaesthesia. In the operating
room, after the infusion of 500 ml of Ringer’s
solution via an intravenous cannula, a 20-gauge
epidural catheter was inserted through an
18-gauge Tuohy needle into the epidural space at
low thoracic levels. The epidural catheter was direc-
ted cephalad for a distance of 4 cm and fixed to
the back of the patient. As soon as the patient
was in a supine position, a test dose of 3 ml of
levobupivacaine (5 mg/ml) (Chirocaine, Abbott,
Louvain-la-Neuve, Belgium) was injected through
the catheter.
Anaesthesia was maintained with sevoflurane in
50% oxygen in air or nitrous oxide, combined with
sufentanil and non-depolarising muscle relaxant.
Three to six millilitres of 5 mg/ml levobupivacaine
were injected through the epidural catheter for the
surgical procedure. If surgery lasted longer than 2 h,
patients received a re-injection of half of the volume
of the local anaesthetic using the same concentra-
tion. After completion of the operation and tracheal
extubation, patients were transferred to the Post-
Anaesthesia Care Unit (PACU) where they
remained under constant observation for approxi-
mately 4 h. In a random fashion, using a computer-
generated random number table, the patients
received either CEI with 5 mg/ml levobupivacaine
at 3 ml/h (group 1, n ¼ 24) or 1.5 mg/ml levobupi-
vacaine at 10 ml/h (group 2, n ¼ 22), or PCEA levo-
bupivacaine at 1.5 mg/ml as a 3.3-ml bolus on
demand, with a lockout interval of 20 min (group
3, n ¼ 22), or 5 mg/ml as a 1-ml bolus on demand,
with a similar lockout interval (group 4, n ¼ 22)
without background infusion. The same pump
(Abbott aim plus, Abbott Laboratories, North
Chicago, IL) was used for all patients. Devices
were directly connected on arrival in the PACU
and epidural infusion was started, independent of
the VAS score. Patients were blind to the drug con-
centration administered epidurally. No extra bolus
injection or change in the infusion rate was allowed.
For further post-operative pain relief patients
received six-hourly intravenous propacetamol (2 g)
and ketorolac (60 mg) within 24 h, unless there
were medical or surgical contraindications. Rescue
medication via morphine was provided via subcu-
taneous injections after evaluation of the VAS every
4 h. The consumption of analgesic drugs was
recorded during the 48-h study period. After 48 h,
the infusion of levobupivacaine was discontinued
and alternative analgesia was provided.
On arrival in the PACU, patients were asked to
rate their pain experience on the VAS device. This
process was repeated every 2 h for the first 4 h.
When the patient was moved to the general surgical
ward, it was continued every 4 h for 48 h. Only rest
pain was assessed, defined as the pain experienced
at this time point by the patient whilst lying in bed.
The pain threshold was set at 3 cm on the VAS (19).
Nausea intensity was evaluated at the same time
interval using a VAS device, and vomiting was
recorded as either present or absent by direct obser-
vation or by spontaneous complaint from the
patient. Nausea was defined as a patient’s rating
score of more than 4 cm on the VAS (18). Rescue
medications given for nausea and/or vomiting were
recorded. The cephalad level of sensory block was
evaluated by loss of sensation to cold using ether
swabs at the same time. If the levels of sensory block
on the right and left sides were different, the most
cephalad was recorded. In the case of sensory block
exceeding Th4, epidural infusion was stopped until
the return of an upper level below this limit. Motor
blockade was assessed according to a modified
Bromage scale (0, no motor block; I, inability to
raise extended legs; II, inability to flex knees; III,
inability to flex ankle joints) (20). Nurses, who
were blind to the type of epidural solution and
mode of delivery, collected the data.
Hypotension was defined as a 30% decrease in
systolic blood pressure compared with baseline,
bradycardia was defined as a heart rate of less
than 50 beats/min, and bradypnoea was defined
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as a respiratory rate of less than 10 breaths/min.
Baseline values were measured at the time of the
pre-operative visit. Sedation was recorded on a
four-point scale (0, no signs of sedation; 1, mild
sedation; 2, moderate sedation; 3, severe sedation).
The patients were questioned every 4 h to deter-
mine the presence of early numbness or any warn-
ing signs of local anaesthetic systemic toxicity, such
as circumoral numbness and tinnitus.
On days 1 and 2, the patients were visited by a
pain nurse from the Acute Pain Service who
interviewed them about their satisfaction with
post-operative analgesia. The quality of pain man-
agement was judged by the patient on a four-point
scale (1, very dissatisfied; 2, dissatisfied; 3, satisfied;
4, very satisfied).
Statistical analysis
Results were expressed as the means  standard
deviation for quantitative variables, the median for
the upper level of dermatomal sensory blockade
and the frequency for categorical findings. Time-
related VAS measurements were summarised
using a series of pain indicators described elsewhere
(21): AUC, area under the VAS—time curve (cm2);
VASmax, peak of VAS (cm); VASmean, mean VAS
(cm); PVAS > 3, the persistence of VAS over 3 cm,
i.e. the time period during which VAS was above
the critical threshold (h). The comparison of mean
values was performed using Student’s t-test,
whereas proportions were compared by the classical
chi-squared test. The general linear model (GLM)
was used to analyse repeated measures of continu-
ous data. The GLM tests two null hypotheses as
follows: 1, time has no effect on the variable,
which means that the variable mean of the com-
bined groups does not vary over time; 2, the time
patterns are equal between the two groups, which
means that the difference between the mean of each
group is the same at every time point. The
Bonferroni test, based on Student’s t-statistic, was
used for post hoc testing. Upper dermatomal levels
of sensory block were compared using the Mann
—Whitney U-test. The number of patients included
in the study was based on our previous results and
on a power calculation assuming a 20% difference in
VAS pain scores with a ¼ 0.05 and b ¼ 0.20 (12, 13).
All statistical calculations were carried out using the
SAS package (SAS Institute, Cary, NC; version 6.12)
and always using all data available. Results were
considered to be significant at the 5% critical level
(P < 0.05).
Results
Eight patients were excluded as a result of protocol
deviation (one patient in the 1.5 mg/ml CEI group),
lack of data recording (two patients in the 1.5 mg/
ml CEI group, three patients in the 1.5 mg/ml
PCEA group and one patient in the 5 mg/ml
PCEA group) or accidental removal of the catheter
(one patient in the 5 mg/ml CEI group). Eighty-two
patients with complete case report forms were
included in the study (20 in the 1.5 mg/ml and 21
in the 5 mg/ml CEI groups, 21 in the 1.5 mg/ml
and 20 in the 5 mg/ml PCEA groups). In these
patients, epidural catheters were functioning until
the end of the observation period. The patient char-
acteristics and distribution according to the type of
surgery are displayed in Table 1. The demographic
data, baseline recordings and type of surgery were
similar in the four groups. Specifically, there was no
difference in age range between the four groups.
The level of insertion of the epidural catheter was
low thoracic (Th8—Th11). In the 5 mg/ml group, the
catheters were inserted slightly lower (Th10—L1). No
cases of accidental dural puncture occurred. At the
time of surgery, patients received the same amount
of intravenous sufentanil (25  10 mg in the 1.5 mg/
ml CEI group, 20  8 mg in the 5 mg/ml CEI group,
23  9 mg in the 1.5 mg/ml PCEA group and
23  7 mg in the 5 mg/ml PCEA group; P ¼ 0.38).
There was no difference between the groups in the
amount of peri-operative epidural levobupivacaine
used (53  21 mg in the 1.5 mg/ml CEI group,
59  22 mg in the 5 mg/ml CEI group,
51  16 mg in the 1.5 mg/ml PCEA group and
53  14 mg in the 5 mg/ml PCEA group; P ¼ 0.50).
The quality of anaesthesia was judged to be
adequate in all patients by the attending
anaesthesiologist.
The median upper level of sensory blockade at the
different time points after surgery is illustrated in
Fig. 1. In the 1.5 mg/ml groups, sensory block was
more extensive in the CEI group (Th7) than in the
PCEA group (Th8—Th9) (P < 0.01). For the high-
concentration solutions, sensory block was higher
in the PCEA group during the first 24 h (Th7 vs.
Th9 in the CEI group; P < 0.01) No upper level
above Th4 was observed in any patient.
Figure 2 shows the VAS pain scores during the
first 48 post-operative hours in the four groups.
VAS scores for pain at rest were higher in the
PCEA groups (P ¼ 0.019; GLM statistics). The
values of the pain indicators are displayed in
Table 2. AUC, VASmax, VASmean and PVAS > 3
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were significantly higher in the PCEA groups. No
relationship was found between the type of surgery
and the efficacy of pain relief.
Post-operative analgesic consumption is dis-
played in Table 2. The total amount of levobupiva-
caine consumed after 48 h was higher in the two
CEI groups (720.0  0.0 mg) than in the PCEA
groups (170  103 mg in the 1.5 mg/ml group and
182  110 mg in the 5 mg/ml group; P < 0.001). In
the PCEA groups, levobupivacaine consumption
decreased during the second post-operative 24 h
(Table 2). Propacetamol was given to all patients
and ketorolac was administered to 20 (100%)
patients in the 1.5 mg/ml CEI group, 18 (85.7%)
patients in the 5 mg/ml CEI group, 17 (81.0%)
patients in the 1.5 mg/ml PCEA group and 15
(75.0%) patients in the 5 mg/ml PCEA group
(P ¼ 0.14). The variation of non-steroidal anti-
inflammatory drug (NSAID) administration
occurred as a result of medical contraindications.
A significant difference was observed between the
two 1.5 mg/ml groups (P ¼ 0.039). Rescue analge-
sia, represented by morphine consumption, was
similar in the four groups (P ¼ 0.21). No difference
could be found between the two groups with regard
to nausea and vomiting (P ¼ 0.10). No life-
threatening respiratory events associated with
opioid administration were reported during the
study period.
The Bromage score was decreased to zero within
the 48-h period for all but one patient in the PCEA
groups. In the 5 mg/ml CEI group, eight patients
presented a motor blockade score of  I between 8
and 40 h. In the 1.5 mg/ml PCEA group, one
patient presented a Bromage score of I and another
a score of II during the 48-h study period (Table 2).
Figure 3 displays the evolution of the blood
pressure and heart rate. There was a significant
difference in haemodynamic variables: systolic and
diastolic blood pressures were lower in the 1.5 mg/
ml CEI group compared with the 1.5 mg/ml PCEA
group (P ¼ 0.036). No difference was observed in
the 5 mg/ml groups. GLM statistics showed a
highly significant time effect on the variables
(P < 0.001), a significant time pattern (P < 0.001)
and significantly different overall means of the
groups (P < 0.001). No vasoconstrictors or atropine
were given for the treatment of hypotension or bra-
dycardia during the study period. No sedation,
respiratory depression or pruritus was observed in
any patient. No patient complained of warning
signs of local anaesthetic systemic toxicity. All
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satisfied with the quality of pain management
(Table 2).
Discussion
The results of the present study show that thoracic
CEI using opioid-free levobupivacaine provides an
equal quality of post-operative analgesia as PCEA,
without background infusion, after lower abdom-
inal surgery. The VAS pain scores were very low in
both groups, i.e. below 3 cm during the study
period. Our data support the view that altering
the concentration and volume of levobupivacaine
results in the same quality of analgesia after CEI or
PCEA administration. Minimal side-effects were
observed with better haemodynamic stability in
the large-concentration/small-volume groups than
in the small-concentration/large-volume groups.
All groups achieved similar levels of patient satis-
faction. However, the total amount of levobupiva-
caine infused was higher in the CEI groups
(720  0 mg) than in the PCEA groups
(170  103 mg in the 1.5 mg/ml group and
182  110 mg in the 5 mg/ml group). The
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Fig. 1. Evolution of the median upper sensory dermatomal level in the four groups of patients during the 48-h study period. Concentration
(1.5 and 5 mg/ml) refers to levobupivacaine. CEI, continuous epidural infusion; PCEA, patient-controlled epidural analgesia; Th, thoracic.
Sensory block was more extensive in the 1.5 mg/ml CEI and 5 mg/ml PCEA groups (P < 0.01; general linear model statistics). *P < 0.05
(Mann—Whitney U-test).
Time (h)







































Fig. 2. Evolution of the mean visual analogue scale (VAS) scores at rest, expressed in centimeters (cm), in the four groups of patients during
the 48-h study period. Concentration (1.5 and 5 mg/ml) refers to levobupivacaine. CEI, continuous epidural infusion; PCEA, patient-
controlled epidural analgesia. Errors bars indicate standard deviation. VAS pain scores were higher in the PCEA groups (P ¼ 0.019; general
linear model statistics). *P < 0.05 (Student’s t-test).
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Our results on the relative effect of the concentra-
tion and volume of local anaesthetics are in accord-
ance with previous studies (5, 7, 23—26). Duggan
et al. (5) showed that the onset and recovery from
surgical analgesia were similar with 7.5 and 5 mg/
ml bupivacaine solutions when administered at the
same dose. In the post-operative period, Laveaux
et al. (23) compared the analgesic efficacy and
side-effects of thoracic CEI using bupivacaine with
sufentanil at high concentration/low volume vs.
low concentration/high volume. They showed
excellent analgesia and no difference in the inci-
dence of side-effects in the two groups. These
authors concluded that the total dose of the local
anaesthetic was more important than the concentra-
tion or volume of the solution. Mogensen et al. (24)
showed that pain relief and regression of analgesia
were similar during CEI of either 8 ml/h of 5 mg/ml
bupivacaine or 16 ml/h of 2.5 mg/ml bupivacaine.
Similar results were reported by Scott et al. (25).
Murdoch et al. (26) observed that levobupivacaine
2.5 mg/ml as CEI provided better post-operative
analgesia without any significant increase in motor
blockade when compared with a concentration of
1.25 mg/ml. Recently, Dernedde et al. (12, 13) have
demonstrated that the same dose of opioid-free levo-
bupivacaine provides an equal quality of analgesia in
small- or large-volume CEI.
However, as mentioned in the introductory sec-
tion, there are some discrepancies in the literature
concerning the analgesic effects of large-concentra-
tion/small-volume local anaesthetics. After thoracic
surgery, Snijdelaar et al. (27) found better analgesia
with high-volume/low-concentration CEI of epi-
dural local anaesthetics than with low-volume/
high-concentration CEI. In their study, they used a
smaller amount of bupivacaine, i.e. 7.5—10 mg/h,
than the 15 mg/h used in our study. This could
contribute to the higher incidence of pain at rest
experienced by their patients. Liu et al. (14), using
PCEA after lower abdominal surgery, observed that
a lower concentration of a similar amount of epi-
dural ropivacaine/fentanyl provided equal analge-
sia with less motor blockade when compared with
higher concentrations of the local anaesthetic.
However, they placed epidural catheters at the
Th12—L2 interspaces. It has already been shown
that the placement of catheters in proximity to the
lumbar spinal segments increases the risk of motor
block when compared with a more cephalad
approach (2). Whiteside et al. (15), using the same
combination of drugs after gynaecological surgery,
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PCEA appeared to be satisfactory for the treatment
of post-operative pain and to decrease the dose of
drugs used in comparison with a low-volume/high-
concentration PCEA. Standl et al. (3) showed that
PCEA using local anaesthetic plus sufentanil pro-
vided at least as good or even better post-operative
pain relief than CEI with comparable side-effects.
Our study differs considerably from these pre-
vious experiments because we did not add any
opioid epidurally and focused only on local anaes-
thetic action. Administration of a high volume of
opioid associated with the local anaesthetic could
produce more extensive sensory block as a result
of greater anatomic spread and interaction with opi-
ate receptors (2, 27). Opioids also limit the regres-
sion of the sensory block observed with local
anaesthetics alone and improve the quality of pain
relief (28). This makes a comparison with our results
difficult.
It is commonly stated that CEI using highly
concentrated local anaesthetics can cause increasing
motor weakness (3). We administered the local
anaesthetics at a low thoracic level to maximise
the analgesic effects in the thoracoabdominal
somatosensory distribution, where motor effects
are not clinically significant. In the PCEA groups,
Bromage scores were zero at all time points
with concentrations of 1.5 and 5 mg/ml. We
observed higher motor blockade with the CEI
delivery mode than with the PCEA mode, specifi-
cally in the 5 mg/ml group. In these patients,
epidural catheters were inserted at a lower level
(Th10—L1) than in the other groups, increasing the
risk of motor blockade (2). Similarly, the cephalad
Time (h)
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Fig. 3. Evolution of mean systolic (sys) and diastolic (dia) blood pressure (BP) in the four groups of patients during the 48-h study period.
Concentration (1.5 and 5 mg/ml) refers to levobupivacaine. CEI, continuous epidural infusion; PCEA, patient-controlled epidural
analgesia. Errors bars indicate standard deviation. Blood pressure was lower in the 1.5 mg/ml CEI group than in the 1.5 mg/ml PCEA
group (P ¼ 0.036; general linear model statistics). *P < 0.05 (Student’s t-test).
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level of the sensory block was lower in the 5 mg/ml
CEI group.
The cephalad extent of sensory block was more
extensive in the 1.5 mg/ml CEI and 5 mg/ml PCEA
groups, with no difference in the other two groups.
Systolic and diastolic blood pressures were lower in
the 1.5 mg/ml CEI group than in the 1.5 mg/ml
PCEA group, indicating a relationship between
sympathetic blockade and cephalad spread.
Previous reports have shown that an increase in
epidural injected volume does not result in a linear
increase in block height (5, 29, 30). Unfortunately,
we did not assess the caudal spread of sensory
block. When examining the different factors influ-
encing the spread of the local anaesthetic, Simon
et al. (31) showed that age influences the spread of
the neural block, as well as the absorption and
disposition of the local anaesthetic after epidural
administration of levobupivacaine. The small
number of patients included in this study did not
enable us to reveal an effect of age on the upper
level of analgesia in the elderly. Further study
should also focus on the pharmacokinetics of
levobupivacaine in the two modes of delivery,
mainly in CEI.
In our study, we did not use background infusion
in the PCEA groups. Numerous studies have sup-
ported the use of PCEA associated with background
infusion (2, 32). Komatsu et al. (33) showed the
advantages of the use of a PCEA background
infusion employing a local anaesthetic and opioid
mixture following upper abdominal surgery. These
included a decreased incidence and degree of post-
operative pain, without an increase in serious side-
effects, partly supporting our results. Other data
suggest that there is no advantage of adding a con-
tinuous infusion in PCEA because of an increase in
the incidence of side-effects, i.e. nausea and vomit-
ing, and motor blockade (34). It should be noted
that, in the study of Wong et al. (34), using a
combination of ropivacaine and fentanyl, epidural
catheters were placed at the lumbar level (L2—L4),
which could explain the higher occurrence of motor
blockade. Nevertheless, the effect of concentration
vs. volume of local anaesthetic in PCEA with back-
ground infusion should be evaluated.
Tachyphylaxis did not occur in any of the groups.
Furthermore, in the PCEA group, levobupivacaine
consumption decreased during the second day rela-
tive to the first 24 h. These results are in line with
Lipfert’s statement that tachyphylaxis is not linked
to the mode of administration, i.e. intermittent vs.
continuous (35).
The most important limitation related to the study
design was that only rest pain was assessed. Further
studies need to focus on pain during mobilisation or
coughing. Nevertheless, the goal of totally pain-free
patients regardless of movement may not be realis-
tic with an epidural pain programme, as recently
stated by Andersen et al. (36).
Finally, it may be interesting to evaluate the use of
a high concentration of the local anaesthetic for
thoracic epidural analgesia. The 5 mg/ml levobupi-
vacaine solution is ready to use. This could result in
fewer administration errors and decreased nursing
time and pharmacy preparation costs. Furthermore,
as CEI induces the same quality of pain relief as
PCEA, there is no need for sophisticated, expensive
infusion devices, such as PCEA pumps and
disposables.
In conclusion, levobupivacaine provides an equal
quality of post-operative analgesia in low or high
volume and in the two delivery modes: thoracic CEI
or PCEA. This is in accordance with the assumption
that the total dose, and not the volume or con-
centration of the local anaesthetic, determines the
quality of analgesia.
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